71 results
Interdisciplinary therapeutic strategy in a low-risk patient with aortic stenosis and preserved life expectancy
05 Mar 2026
A 71-year-old low-risk patient with symptomatic severe aortic stenosis and preserved ventricular function presents with progressive dyspnoea and chest pain. With long life expectancy, the choice of treatment demands careful interdisciplinary planning. How would you treat?

Author

Author

Author

Author
How should I treat a torrential tricuspid valve regurgitation in a young patient who remains symptomatic despite optimal medical therapy?
19 Feb 2026
A frail patient presents with worsening NYHA class III dyspnoea and peripheral oedema despite optimal medical therapy. Previously managed conservatively, severe tricuspid regurgitation has progressed to a torrential grade, with right-sided chamber dilatation and complex valve anatomy.
How would you treat this patient?

Author

Author
LAA closure with CT planning: challenging inferior chicken wing morphology
11 Feb 2026
This 77-year-old woman with paroxysmal AF and prior GI bleeding is referred for LAA closure, but CT reveals a shallow, inferior chicken-wing morphology that complicates device selection and planning. How would your Heart Team approach this challenging case?

Author
M-TEER with Mitraclip Gen5
03 Feb 2026
An 83-year-old female patient with HFrEF due to NICM and a history of arterial hypertension and persistent atrial fibrillation was referred with worsening exertional dyspnea, severe functional mitral regurgitation and moderate tricuspid regurgitation.
How would you treat this patient?

Author
A challenging valve-in-valve scenario in a patient with prior aortic coarctation repair
02 Feb 2026
This case features a 79-year-old patient with severe aortic stenosis and a degenerated surgical bioprosthesis, who previously underwent complex aortic surgery for coarctation.
Redo surgery was high-risk, so a transcatheter valve-in-valve procedure was chosen.
Explore the case to see how anatomy, prosthesis sizing, and vascular access options guide...

Author

Author

Author

Author

Author
Severe mitral regurgitation in a patient at high risk for surgery with a suboptimal anatomy for M-TEER: what other options can we find?
04 Feb 2026
A 78-year-old male presents with recurrent hospitalisations for HFpEF and severe degenerative MR. Multimodality imaging reveals fibro-calcific leaflet disease, restricted motion, and a short posterior leaflet, making him a suboptimal candidate for M-TEER and prompting consideration of transcatheter mitral valve replacement. How would you treat?

Author

Author
Author
Impact of guideline-directed medical therapy on long-term outcome after tricuspid TEER
29 Jan 2026
A 79-year-old woman with advanced right heart failure (NYHA III) was referred after repeated hospitalisations for decompensation despite optimal medical therapy. Echocardiography revealed torrential functional tricuspid regurgitation with suitable anatomy for T-TEER. Given her high surgical risk (TRISCORE 7/12) and borderline pulmonary hypertension, how would you...

Author

Author
New roads begin where old ones end: a TAVI case
12 Jan 2026
An 85-year-old woman presents with exertional dyspnea and angina, alongside severe paradoxical low-flow, low-gradient aortic stenosis, marked mitral and tricuspid valve disease, and two-vessel coronary artery disease. Frailty markers and hostile pelvic anatomy further complicate her profile.
How would your Heart Team approach this challenging case?

Author

Author
When the first TAVI fails: no panic, just planning
19 Jan 2026
An 81-year-old man with history of severe aortic stenosis previously treated with a balloon-expandable transcatheter valve was referred for progressive exertional dyspnea due to bioprosthetic valve degeneration.
How would you treat this patient?

Author
Treating severe restenosis of a 20-mm balloon-expanding valve after a transapical approach with a risk of coronary obstruction
05 Nov 2025
In this challenging redo TAVI case, an 87-year-old woman presented with severe bioprosthetic valve restenosis and advanced heart failure symptoms, eight years after a previous transapical implantation.
Her frailty, prior surgical approach, and complex anatomy—with low coronary heights and a stent frame extending beyond the sinotubular junction—posed...

Author

Author

Author
Author

Author

Author